Jeff Riddell1, Alexander Tran2, Rimon Bengiamin3, Gregory W Hendey4, Patil Armenian3. 1. Division of Emergency Medicine, University of Washington, Seattle, WA, USA. Electronic address: jeffridd@uw.edu. 2. St. Louis University School of Medicine, USA. 3. Department of Emergency Medicine, University of California San Francisco - Fresno, Fresno, CA, USA. 4. Department of Emergency Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Abstract
OBJECTIVE: Emergency physicians often need to control agitated patients who present a danger to themselves and hospital personnel. Commonly used medications have limitations. Our primary objective was to compare the time to a defined reduction in agitation scores for ketamine versus benzodiazepines and haloperidol, alone or in combination. Our secondary objectives were to compare rates of medication redosing, vital sign changes, and adverse events in the different treatment groups. METHODS: We conducted a single-center, prospective, observational study examining agitation levels in acutely agitated emergency department patients between the ages of 18 and 65 who required sedation medication for acute agitation. Providers measured agitation levels on a previously validated 6-point sedation scale at 0-, 5-, 10-, and 15-min after receiving sedation. We also assessed the incidence of adverse events, repeat or rescue medication dosing, and changes in vital signs. RESULTS: 106 patients were enrolled and 98 met eligibility criteria. There was no significant difference between groups in initial agitation scores. Based on agitation scores, more patients in the ketamine group were no longer agitated than the other medication groups at 5-, 10-, and 15-min after receiving medication. Patients receiving ketamine had similar rates of redosing, changes in vital signs, and adverse events to the other groups. CONCLUSION: In highly agitated and violent emergency department patients, significantly fewer patients receiving ketamine as a first line sedating agent were agitated at 5-, 10-, and 15-min. Ketamine appears to be faster at controlling agitation than standard emergency department medications.
OBJECTIVE: Emergency physicians often need to control agitated patients who present a danger to themselves and hospital personnel. Commonly used medications have limitations. Our primary objective was to compare the time to a defined reduction in agitation scores for ketamine versus benzodiazepines and haloperidol, alone or in combination. Our secondary objectives were to compare rates of medication redosing, vital sign changes, and adverse events in the different treatment groups. METHODS: We conducted a single-center, prospective, observational study examining agitation levels in acutely agitated emergency department patients between the ages of 18 and 65 who required sedation medication for acute agitation. Providers measured agitation levels on a previously validated 6-point sedation scale at 0-, 5-, 10-, and 15-min after receiving sedation. We also assessed the incidence of adverse events, repeat or rescue medication dosing, and changes in vital signs. RESULTS: 106 patients were enrolled and 98 met eligibility criteria. There was no significant difference between groups in initial agitation scores. Based on agitation scores, more patients in the ketamine group were no longer agitated than the other medication groups at 5-, 10-, and 15-min after receiving medication. Patients receiving ketamine had similar rates of redosing, changes in vital signs, and adverse events to the other groups. CONCLUSION: In highly agitated and violent emergency department patients, significantly fewer patients receiving ketamine as a first line sedating agent were agitated at 5-, 10-, and 15-min. Ketamine appears to be faster at controlling agitation than standard emergency department medications.
Authors: Christoph Kraus; Daniel Wasserman; Ioline D Henter; Elia Acevedo-Diaz; Bashkim Kadriu; Carlos A Zarate Journal: Drug Discov Today Date: 2019-08-02 Impact factor: 7.851
Authors: Ambrose H Wong; Jessica M Ray; Marc A Auerbach; Arjun K Venkatesh; Caitlin McVaney; Danielle Burness; Christopher Chmura; Thomas Saxa; Mark Sevilla; Colin T Flood; Amitkumar Patel; Travis Whitfill; James D Dziura; Kimberly A Yonkers; Andrew Ulrich; Steven L Bernstein Journal: BMJ Open Date: 2020-06-30 Impact factor: 2.692
Authors: David Barbic; Gary Andolfatto; Brian Grunau; Frank X Scheuermeyer; William MacEwan; William G Honer; Hubert Wong; Skye P Barbic Journal: Trials Date: 2018-11-26 Impact factor: 2.279
Authors: Esther W Chan; Kim S J Lao; Lam Lam; Sik-Hon Tsui; Chun-Tat Lui; Chi-Pang Wong; Colin A Graham; Chi-Hung Cheng; Tong-Shun Chung; Hiu-Fung Lam; Soo-Moi Ting; Jonathan C Knott; David M Taylor; David C M Kong; Ling-Pong Leung; Ian C K Wong Journal: EClinicalMedicine Date: 2021-02-11